

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * detection of visible light (GO:0009584) | 9.89673565 |
| 2 | * detection of light stimulus (GO:0009583) | 9.65666965 |
| 3 | regulation of guanylate cyclase activity (GO:0031282) | 9.23291493 |
| 4 | * protein-chromophore linkage (GO:0018298) | 8.85716858 |
| 5 | retinal rod cell development (GO:0046548) | 8.42764588 |
| 6 | * visual perception (GO:0007601) | 8.24604839 |
| 7 | * sensory perception of light stimulus (GO:0050953) | 8.14930767 |
| 8 | GMP metabolic process (GO:0046037) | 8.10076200 |
| 9 | cellular response to light stimulus (GO:0071482) | 7.14862997 |
| 10 | * detection of external stimulus (GO:0009581) | 6.75281389 |
| 11 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 6.69844252 |
| 12 | * detection of abiotic stimulus (GO:0009582) | 6.61723034 |
| 13 | regulation of cGMP metabolic process (GO:0030823) | 6.20157067 |
| 14 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 6.19738180 |
| 15 | positive regulation of cGMP biosynthetic process (GO:0030828) | 6.01694450 |
| 16 | eye photoreceptor cell differentiation (GO:0001754) | 5.70120228 |
| 17 | photoreceptor cell differentiation (GO:0046530) | 5.70120228 |
| 18 | retina development in camera-type eye (GO:0060041) | 5.67957318 |
| 19 | regulation of cGMP biosynthetic process (GO:0030826) | 5.64864982 |
| 20 | positive regulation of cGMP metabolic process (GO:0030825) | 5.30935045 |
| 21 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.87777283 |
| 22 | cellular response to radiation (GO:0071478) | 4.58941432 |
| 23 | adaptation of signaling pathway (GO:0023058) | 4.45169308 |
| 24 | estrogen biosynthetic process (GO:0006703) | 4.36344701 |
| 25 | nonmotile primary cilium assembly (GO:0035058) | 4.33410075 |
| 26 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.29504336 |
| 27 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.26521807 |
| 28 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.95437320 |
| 29 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 3.92798904 |
| 30 | * sensory perception (GO:0007600) | 3.89311051 |
| 31 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.88643241 |
| 32 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.82018246 |
| 33 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.77233424 |
| 34 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.76308904 |
| 35 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.71470790 |
| 36 | * response to light stimulus (GO:0009416) | 3.71452966 |
| 37 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.69034748 |
| 38 | behavioral response to ethanol (GO:0048149) | 3.60734359 |
| 39 | retina layer formation (GO:0010842) | 3.57886492 |
| 40 | response to histamine (GO:0034776) | 3.56395989 |
| 41 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 3.56149585 |
| 42 | membrane hyperpolarization (GO:0060081) | 3.48120172 |
| 43 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.46683775 |
| 44 | positive regulation of ERBB signaling pathway (GO:1901186) | 3.44418092 |
| 45 | positive regulation of neurotransmitter transport (GO:0051590) | 3.40186870 |
| 46 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.39009390 |
| 47 | short-term memory (GO:0007614) | 3.37545002 |
| 48 | neuron development (GO:0048666) | 3.33043415 |
| 49 | chemosensory behavior (GO:0007635) | 3.27405503 |
| 50 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.27388237 |
| 51 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.27388237 |
| 52 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.15129625 |
| 53 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.13466877 |
| 54 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.12846088 |
| 55 | protein localization to synapse (GO:0035418) | 3.12739854 |
| 56 | protein prenylation (GO:0018342) | 3.12108585 |
| 57 | prenylation (GO:0097354) | 3.12108585 |
| 58 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.08868307 |
| 59 | regulation of penile erection (GO:0060405) | 3.01448338 |
| 60 | synaptic vesicle maturation (GO:0016188) | 2.96676407 |
| 61 | phospholipid translocation (GO:0045332) | 2.92144438 |
| 62 | lipid translocation (GO:0034204) | 2.92144438 |
| 63 | positive regulation of cyclase activity (GO:0031281) | 2.82724610 |
| 64 | righting reflex (GO:0060013) | 2.79181524 |
| 65 | * retinoid metabolic process (GO:0001523) | 2.77643882 |
| 66 | response to pheromone (GO:0019236) | 2.77310379 |
| 67 | startle response (GO:0001964) | 2.68918113 |
| 68 | cellular potassium ion homeostasis (GO:0030007) | 2.67780820 |
| 69 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.66916369 |
| 70 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.66407755 |
| 71 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.62588128 |
| 72 | retina homeostasis (GO:0001895) | 2.60724363 |
| 73 | positive regulation of lyase activity (GO:0051349) | 2.58050515 |
| 74 | * diterpenoid metabolic process (GO:0016101) | 2.57528598 |
| 75 | behavioral response to cocaine (GO:0048148) | 2.55952087 |
| 76 | dopamine receptor signaling pathway (GO:0007212) | 2.54656573 |
| 77 | * response to radiation (GO:0009314) | 2.51086138 |
| 78 | mitochondrion transport along microtubule (GO:0047497) | 2.50159731 |
| 79 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.50159731 |
| 80 | synaptic transmission, dopaminergic (GO:0001963) | 2.48652608 |
| 81 | negative regulation of cation channel activity (GO:2001258) | 2.48257855 |
| 82 | arachidonic acid secretion (GO:0050482) | 2.45214212 |
| 83 | icosanoid secretion (GO:0032309) | 2.45214212 |
| 84 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.45078482 |
| 85 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.45078482 |
| 86 | post-embryonic morphogenesis (GO:0009886) | 2.43004447 |
| 87 | sodium ion export (GO:0071436) | 2.38549484 |
| 88 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.37510692 |
| 89 | * terpenoid metabolic process (GO:0006721) | 2.35819117 |
| 90 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 17.5171926 |
| 91 | rhodopsin mediated signaling pathway (GO:0016056) | 17.1229865 |
| 92 | retinal cone cell development (GO:0046549) | 17.1127355 |
| 93 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.6183476 |
| 94 | detection of light stimulus involved in visual perception (GO:0050908) | 11.6183476 |
| 95 | photoreceptor cell development (GO:0042461) | 11.3008482 |
| 96 | eye photoreceptor cell development (GO:0042462) | 10.9835412 |
| 97 | photoreceptor cell maintenance (GO:0045494) | 10.7393530 |
| 98 | * phototransduction, visible light (GO:0007603) | 10.2408563 |
| 99 | * phototransduction (GO:0007602) | 10.2255594 |
| 100 | positive regulation of guanylate cyclase activity (GO:0031284) | 10.2174423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.62613299 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.51801787 |
| 3 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 3.33937478 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.92194122 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.62932496 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.60575108 |
| 7 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.32085971 |
| 8 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.16413413 |
| 9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.08935099 |
| 10 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.92000936 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.90518473 |
| 12 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.89142399 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.87376658 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.85744652 |
| 15 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.84224340 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.80345368 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.77195554 |
| 18 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71622018 |
| 19 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.71172440 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.69924533 |
| 21 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.69478556 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.65863212 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.62606030 |
| 24 | AR_19668381_ChIP-Seq_PC3_Human | 1.62374709 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.61356218 |
| 26 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55978930 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52431031 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52263231 |
| 29 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51351800 |
| 30 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.45792610 |
| 31 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.45064256 |
| 32 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.43110117 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40606242 |
| 34 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40117421 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40053607 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37094496 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.36270339 |
| 38 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.36072585 |
| 39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.36072585 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34988362 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34630709 |
| 42 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.31260581 |
| 43 | TBL1_22424771_ChIP-Seq_293T_Human | 1.30057736 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28898637 |
| 45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.25307527 |
| 46 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.24050907 |
| 47 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.22604980 |
| 48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.21598611 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.21119673 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21016961 |
| 51 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20989825 |
| 52 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.18968303 |
| 53 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.18508929 |
| 54 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.18476704 |
| 55 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.17146118 |
| 56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16281654 |
| 57 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.15490791 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15427228 |
| 59 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.14751428 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14488207 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13503211 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13410256 |
| 63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12222253 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11897689 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11249640 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09159185 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.07137137 |
| 68 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05818109 |
| 69 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.05418083 |
| 70 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.04988927 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03194332 |
| 72 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01918553 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00894051 |
| 74 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00407667 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00153321 |
| 76 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.99883428 |
| 77 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99774022 |
| 78 | CBP_21632823_ChIP-Seq_H3396_Human | 0.98255659 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95680229 |
| 80 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94711325 |
| 81 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94493964 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94039704 |
| 83 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93368989 |
| 84 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93077304 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.92960538 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92814796 |
| 87 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.92789409 |
| 88 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92577288 |
| 89 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.92455615 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91489047 |
| 91 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90986400 |
| 92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90736089 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90613541 |
| 94 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.89969387 |
| 95 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89616147 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89159702 |
| 97 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.88346200 |
| 98 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88076969 |
| 99 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87043376 |
| 100 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.87032355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 9.84839063 |
| 2 | MP0005253_abnormal_eye_physiology | 6.79671139 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.46448459 |
| 4 | MP0005195_abnormal_posterior_eye | 3.74226077 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.74006908 |
| 6 | MP0001324_abnormal_eye_pigmentation | 3.30980388 |
| 7 | MP0005391_vision/eye_phenotype | 3.23087767 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.74694355 |
| 9 | MP0002229_neurodegeneration | 2.66807355 |
| 10 | * MP0002090_abnormal_vision | 2.49739880 |
| 11 | MP0002638_abnormal_pupillary_reflex | 2.16882441 |
| 12 | MP0003011_delayed_dark_adaptation | 10.9974938 |
| 13 | MP0002752_abnormal_somatic_nervous | 1.88682323 |
| 14 | MP0001764_abnormal_homeostasis | 1.77182529 |
| 15 | MP0001986_abnormal_taste_sensitivity | 1.64913625 |
| 16 | MP0004233_abnormal_muscle_weight | 1.53341833 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 1.51359002 |
| 18 | MP0002653_abnormal_ependyma_morphology | 1.43719394 |
| 19 | MP0002882_abnormal_neuron_morphology | 1.40436301 |
| 20 | MP0004270_analgesia | 1.20016340 |
| 21 | MP0001486_abnormal_startle_reflex | 1.17763486 |
| 22 | MP0001984_abnormal_olfaction | 1.14149405 |
| 23 | MP0001502_abnormal_circadian_rhythm | 1.06858611 |
| 24 | MP0003880_abnormal_central_pattern | 0.98590906 |
| 25 | MP0004885_abnormal_endolymph | 0.93896592 |
| 26 | MP0002332_abnormal_exercise_endurance | 0.93246273 |
| 27 | MP0005197_abnormal_uvea_morphology | 0.80236343 |
| 28 | MP0008004_abnormal_stomach_pH | 0.78515351 |
| 29 | MP0004859_abnormal_synaptic_plasticity | 0.76866053 |
| 30 | MP0002272_abnormal_nervous_system | 0.74898965 |
| 31 | MP0003635_abnormal_synaptic_transmissio | 0.74187038 |
| 32 | MP0002064_seizures | 0.72426451 |
| 33 | MP0003634_abnormal_glial_cell | 0.70281054 |
| 34 | MP0006292_abnormal_olfactory_placode | 0.68695146 |
| 35 | MP0001968_abnormal_touch/_nociception | 0.66725018 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 0.66704654 |
| 37 | MP0002734_abnormal_mechanical_nocicepti | 0.66495742 |
| 38 | MP0002127_abnormal_cardiovascular_syste | 0.65855097 |
| 39 | MP0005394_taste/olfaction_phenotype | 0.62112574 |
| 40 | MP0005499_abnormal_olfactory_system | 0.62112574 |
| 41 | MP0004924_abnormal_behavior | 0.60394466 |
| 42 | MP0005386_behavior/neurological_phenoty | 0.60394466 |
| 43 | MP0002063_abnormal_learning/memory/cond | 0.57712408 |
| 44 | MP0002572_abnormal_emotion/affect_behav | 0.57570343 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 0.56342648 |
| 46 | MP0009046_muscle_twitch | 0.53970981 |
| 47 | MP0001963_abnormal_hearing_physiology | 0.51475856 |
| 48 | MP0002067_abnormal_sensory_capabilities | 0.51296072 |
| 49 | MP0004215_abnormal_myocardial_fiber | 0.50268460 |
| 50 | MP0009745_abnormal_behavioral_response | 0.49850339 |
| 51 | MP0002909_abnormal_adrenal_gland | 0.48919017 |
| 52 | MP0001286_abnormal_eye_development | 0.48341490 |
| 53 | MP0010386_abnormal_urinary_bladder | 0.46390741 |
| 54 | MP0005187_abnormal_penis_morphology | 0.46006567 |
| 55 | MP0003045_fibrosis | 0.45986376 |
| 56 | MP0010368_abnormal_lymphatic_system | 0.44436907 |
| 57 | MP0005620_abnormal_muscle_contractility | 0.43876674 |
| 58 | MP0005376_homeostasis/metabolism_phenot | 0.42157697 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 0.41484593 |
| 60 | MP0008789_abnormal_olfactory_epithelium | 0.41378473 |
| 61 | MP0004130_abnormal_muscle_cell | 0.39314114 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 0.37472099 |
| 63 | MP0003646_muscle_fatigue | 0.36222152 |
| 64 | MP0004742_abnormal_vestibular_system | 0.34693054 |
| 65 | MP0000749_muscle_degeneration | 0.34454952 |
| 66 | MP0008569_lethality_at_weaning | 0.34431070 |
| 67 | MP0003890_abnormal_embryonic-extraembry | 0.33992336 |
| 68 | MP0000631_abnormal_neuroendocrine_gland | 0.33948569 |
| 69 | MP0004085_abnormal_heartbeat | 0.33756891 |
| 70 | MP0000751_myopathy | 0.32173051 |
| 71 | MP0005330_cardiomyopathy | 0.30210455 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 0.28962529 |
| 73 | MP0002066_abnormal_motor_capabilities/c | 0.28923264 |
| 74 | MP0001905_abnormal_dopamine_level | 0.27784564 |
| 75 | MP0003252_abnormal_bile_duct | 0.27645627 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.26548175 |
| 77 | MP0000759_abnormal_skeletal_muscle | 0.24804130 |
| 78 | MP0005365_abnormal_bile_salt | 0.24480031 |
| 79 | MP0004036_abnormal_muscle_relaxation | 0.24410337 |
| 80 | MP0002152_abnormal_brain_morphology | 0.24300497 |
| 81 | MP0002972_abnormal_cardiac_muscle | 0.23712909 |
| 82 | MP0005248_abnormal_Harderian_gland | 0.23477033 |
| 83 | MP0002108_abnormal_muscle_morphology | 0.22933533 |
| 84 | MP0004142_abnormal_muscle_tone | 0.22810228 |
| 85 | MP0002928_abnormal_bile_duct | 0.22423631 |
| 86 | MP0001879_abnormal_lymphatic_vessel | 0.21440655 |
| 87 | MP0005646_abnormal_pituitary_gland | 0.20450731 |
| 88 | MP0008875_abnormal_xenobiotic_pharmacok | 0.20427373 |
| 89 | MP0001915_intracranial_hemorrhage | 0.19735777 |
| 90 | MP0004811_abnormal_neuron_physiology | 0.19088043 |
| 91 | MP0004087_abnormal_muscle_fiber | 0.18866557 |
| 92 | MP0000026_abnormal_inner_ear | 0.17952845 |
| 93 | MP0002184_abnormal_innervation | 0.17858535 |
| 94 | MP0005334_abnormal_fat_pad | 0.17759612 |
| 95 | MP0004043_abnormal_pH_regulation | 0.17712043 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.17691798 |
| 97 | MP0000747_muscle_weakness | 0.17532523 |
| 98 | MP0002971_abnormal_brown_adipose | 0.16400948 |
| 99 | MP0001970_abnormal_pain_threshold | 0.16171227 |
| 100 | MP0002269_muscular_atrophy | 0.15525841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 9.96410482 |
| 2 | Central scotoma (HP:0000603) | 9.21036251 |
| 3 | Abnormal rod and cone electroretinograms (HP:0008323) | 9.13380635 |
| 4 | Pigmentary retinal degeneration (HP:0001146) | 8.67179834 |
| 5 | Scotoma (HP:0000575) | 8.11700397 |
| 6 | Attenuation of retinal blood vessels (HP:0007843) | 7.58011695 |
| 7 | Pendular nystagmus (HP:0012043) | 7.47918110 |
| 8 | * Abnormality of macular pigmentation (HP:0008002) | 7.24125472 |
| 9 | Chorioretinal atrophy (HP:0000533) | 7.22212983 |
| 10 | Decreased central vision (HP:0007663) | 6.86687064 |
| 11 | Abolished electroretinogram (ERG) (HP:0000550) | 6.42934746 |
| 12 | * Photophobia (HP:0000613) | 5.82487638 |
| 13 | Vitreoretinal degeneration (HP:0000655) | 5.46999710 |
| 14 | Type II diabetes mellitus (HP:0005978) | 5.44507144 |
| 15 | Macular degeneration (HP:0000608) | 5.37722893 |
| 16 | Posterior subcapsular cataract (HP:0007787) | 5.31288863 |
| 17 | Severe visual impairment (HP:0001141) | 5.25163000 |
| 18 | Choroideremia (HP:0001139) | 5.01737902 |
| 19 | Cone-rod dystrophy (HP:0000548) | 4.77616776 |
| 20 | Constricted visual fields (HP:0001133) | 4.42832863 |
| 21 | Retinitis pigmentosa (HP:0000510) | 4.22712514 |
| 22 | Increased corneal curvature (HP:0100692) | 4.19280452 |
| 23 | Keratoconus (HP:0000563) | 4.19280452 |
| 24 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.63762283 |
| 25 | Subcapsular cataract (HP:0000523) | 3.33765102 |
| 26 | Retinal atrophy (HP:0001105) | 3.17842493 |
| 27 | Congenital sensorineural hearing impairment (HP:0008527) | 3.16579657 |
| 28 | Progressive visual loss (HP:0000529) | 3.09952172 |
| 29 | Optic disc pallor (HP:0000543) | 2.79473679 |
| 30 | Wide nasal bridge (HP:0000431) | 2.42102117 |
| 31 | Gait imbalance (HP:0002141) | 2.13686849 |
| 32 | Congenital primary aphakia (HP:0007707) | 2.10860730 |
| 33 | Horizontal nystagmus (HP:0000666) | 2.06178716 |
| 34 | Congenital stationary night blindness (HP:0007642) | 14.7418677 |
| 35 | Bony spicule pigmentary retinopathy (HP:0007737) | 11.4593575 |
| 36 | * Dyschromatopsia (HP:0007641) | 10.3621216 |
| 37 | Polar cataract (HP:0010696) | 1.87421417 |
| 38 | Nephrogenic diabetes insipidus (HP:0009806) | 1.85158496 |
| 39 | Medial flaring of the eyebrow (HP:0010747) | 1.76884948 |
| 40 | Severe Myopia (HP:0011003) | 1.72835075 |
| 41 | Poor coordination (HP:0002370) | 1.63007610 |
| 42 | Epileptic encephalopathy (HP:0200134) | 1.54611214 |
| 43 | Optic atrophy (HP:0000648) | 1.53736474 |
| 44 | Dysdiadochokinesis (HP:0002075) | 1.53282630 |
| 45 | Interstitial pulmonary disease (HP:0006530) | 1.47122334 |
| 46 | Vaginal atresia (HP:0000148) | 1.44864490 |
| 47 | Febrile seizures (HP:0002373) | 1.40247989 |
| 48 | Genital tract atresia (HP:0001827) | 1.38837778 |
| 49 | Retinal detachment (HP:0000541) | 1.26900694 |
| 50 | Truncal ataxia (HP:0002078) | 1.24288955 |
| 51 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.21219268 |
| 52 | Progressive cerebellar ataxia (HP:0002073) | 1.20024907 |
| 53 | Genetic anticipation (HP:0003743) | 1.19513593 |
| 54 | True hermaphroditism (HP:0010459) | 1.13154481 |
| 55 | Visual hallucinations (HP:0002367) | 1.10233864 |
| 56 | Pancreatic fibrosis (HP:0100732) | 1.09388811 |
| 57 | Prolonged QT interval (HP:0001657) | 1.05648547 |
| 58 | Broad-based gait (HP:0002136) | 1.04413142 |
| 59 | Astigmatism (HP:0000483) | 1.01153982 |
| 60 | Chorioretinal coloboma (HP:0000567) | 0.98638731 |
| 61 | Macroorchidism (HP:0000053) | 0.98596630 |
| 62 | Left ventricular hypertrophy (HP:0001712) | 0.96629247 |
| 63 | Hyperventilation (HP:0002883) | 0.92376858 |
| 64 | Dysmetric saccades (HP:0000641) | 0.88211016 |
| 65 | Abnormality of the fovea (HP:0000493) | 0.87090751 |
| 66 | Broad foot (HP:0001769) | 0.86752294 |
| 67 | Specific learning disability (HP:0001328) | 0.86694410 |
| 68 | Cystic liver disease (HP:0006706) | 0.86661897 |
| 69 | Abnormal EKG (HP:0003115) | 0.84990637 |
| 70 | Pancreatic cysts (HP:0001737) | 0.83591442 |
| 71 | Hypermetropia (HP:0000540) | 0.82583879 |
| 72 | Recurrent sinusitis (HP:0011108) | 0.81058425 |
| 73 | Hypoplasia of the fovea (HP:0007750) | 0.80100863 |
| 74 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 0.80100863 |
| 75 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 0.80034734 |
| 76 | Asthma (HP:0002099) | 0.79170070 |
| 77 | Gaze-evoked nystagmus (HP:0000640) | 0.79047682 |
| 78 | Abnormality of the fingertips (HP:0001211) | 0.78747058 |
| 79 | Syncope (HP:0001279) | 0.76090548 |
| 80 | Scanning speech (HP:0002168) | 0.75701008 |
| 81 | Depression (HP:0000716) | 0.74408027 |
| 82 | Molar tooth sign on MRI (HP:0002419) | 0.73474712 |
| 83 | Abnormality of midbrain morphology (HP:0002418) | 0.73474712 |
| 84 | Hypoventilation (HP:0002791) | 0.73368197 |
| 85 | Postural instability (HP:0002172) | 0.73196457 |
| 86 | Decreased testicular size (HP:0008734) | 0.72455764 |
| 87 | Aqueductal stenosis (HP:0002410) | 0.71675229 |
| 88 | Chronic hepatic failure (HP:0100626) | 0.70918350 |
| 89 | Sclerocornea (HP:0000647) | 0.69716424 |
| 90 | Furrowed tongue (HP:0000221) | 0.67910064 |
| 91 | Cerebellar dysplasia (HP:0007033) | 0.67535236 |
| 92 | Absence seizures (HP:0002121) | 0.67353979 |
| 93 | Generalized myoclonic seizures (HP:0002123) | 0.66659999 |
| 94 | Urinary bladder sphincter dysfunction (HP:0002839) | 0.66588859 |
| 95 | Truncal obesity (HP:0001956) | 0.65845696 |
| 96 | Abnormality of dental color (HP:0011073) | 0.65506009 |
| 97 | Abnormality of the parathyroid morphology (HP:0011766) | 0.63552573 |
| 98 | Absent speech (HP:0001344) | 0.63298163 |
| 99 | Abnormality of ocular smooth pursuit (HP:0000617) | 0.63210553 |
| 100 | Short foot (HP:0001773) | 0.62930853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.32866893 |
| 2 | PINK1 | 3.10915578 |
| 3 | CAMK1G | 2.10304073 |
| 4 | GRK1 | 11.3943188 |
| 5 | CDK12 | 1.82195815 |
| 6 | CAMK1D | 1.72446901 |
| 7 | ADRBK1 | 1.71821391 |
| 8 | MAPK12 | 1.67922998 |
| 9 | SIK2 | 1.65400447 |
| 10 | MAPK7 | 1.57869140 |
| 11 | STK38 | 1.54359754 |
| 12 | INSRR | 1.51689167 |
| 13 | PNCK | 1.49858758 |
| 14 | HIPK2 | 1.49601048 |
| 15 | BRD4 | 1.47429658 |
| 16 | PAK6 | 1.46487068 |
| 17 | MAP3K4 | 1.43685553 |
| 18 | IRAK2 | 1.37476908 |
| 19 | TAOK3 | 1.35107129 |
| 20 | MARK1 | 1.31685959 |
| 21 | AKT3 | 1.11035385 |
| 22 | SGK2 | 1.08624813 |
| 23 | CSNK1D | 1.08017582 |
| 24 | PRKCH | 1.03333233 |
| 25 | MAP3K10 | 1.02909652 |
| 26 | SGK494 | 1.01901026 |
| 27 | SGK223 | 1.01901026 |
| 28 | SGK3 | 1.01487064 |
| 29 | WNK1 | 1.00973588 |
| 30 | PHKG2 | 0.95459286 |
| 31 | PHKG1 | 0.95459286 |
| 32 | LATS1 | 0.94596684 |
| 33 | MYLK | 0.93428812 |
| 34 | PRKCZ | 0.92330608 |
| 35 | CAMKK1 | 0.91279610 |
| 36 | FES | 0.89294398 |
| 37 | PRKD3 | 0.86530732 |
| 38 | RPS6KA4 | 0.85929267 |
| 39 | ERBB2 | 0.81564941 |
| 40 | EPHA3 | 0.79369864 |
| 41 | MAP2K7 | 0.79301074 |
| 42 | CAMK2D | 0.79261791 |
| 43 | PRKCB | 0.77492917 |
| 44 | ICK | 0.74986687 |
| 45 | MAP2K4 | 0.70883382 |
| 46 | TTK | 0.68178229 |
| 47 | NEK1 | 0.67337332 |
| 48 | PRKAA2 | 0.66242710 |
| 49 | CDK5 | 0.66084438 |
| 50 | PRKAA1 | 0.66012522 |
| 51 | MAP3K7 | 0.63970230 |
| 52 | RPS6KA3 | 0.63004131 |
| 53 | GRK5 | 0.61905762 |
| 54 | DYRK1A | 0.60187363 |
| 55 | PLK2 | 0.59968279 |
| 56 | NTRK3 | 0.59832942 |
| 57 | CAMK1 | 0.58452377 |
| 58 | CDK3 | 0.55997447 |
| 59 | SGK1 | 0.55957552 |
| 60 | PRKACG | 0.55923706 |
| 61 | MINK1 | 0.50978355 |
| 62 | AKT2 | 0.46602277 |
| 63 | CDK9 | 0.46383096 |
| 64 | GSK3B | 0.46052943 |
| 65 | PDK1 | 0.44682337 |
| 66 | CAMK4 | 0.43502686 |
| 67 | MAPK10 | 0.43001863 |
| 68 | PRKD2 | 0.42693922 |
| 69 | ALK | 0.42531719 |
| 70 | PRKDC | 0.42346821 |
| 71 | FRK | 0.40828341 |
| 72 | STK11 | 0.39286534 |
| 73 | MAPK14 | 0.39218304 |
| 74 | MAPK9 | 0.38523834 |
| 75 | RPS6KB1 | 0.36344898 |
| 76 | PRKACA | 0.33913285 |
| 77 | PRKCG | 0.31905678 |
| 78 | PKN1 | 0.31120302 |
| 79 | CDK1 | 0.30883922 |
| 80 | PRKCA | 0.29935202 |
| 81 | DYRK1B | 0.29298281 |
| 82 | MAP3K9 | 0.29203419 |
| 83 | CAMK2A | 0.28775326 |
| 84 | SIK1 | 0.28033334 |
| 85 | JAK1 | 0.27426753 |
| 86 | NEK2 | 0.25202667 |
| 87 | CHEK2 | 0.24340146 |
| 88 | CSNK1G2 | 0.24338412 |
| 89 | MAPK3 | 0.24235593 |
| 90 | CSNK1E | 0.23844328 |
| 91 | MAPK8 | 0.23237775 |
| 92 | PRKG1 | 0.22057186 |
| 93 | RET | 0.21883503 |
| 94 | PLK3 | 0.20737963 |
| 95 | FGFR3 | 0.20236274 |
| 96 | CDC42BPA | 0.19937886 |
| 97 | FER | 0.19541152 |
| 98 | PRKD1 | 0.18818783 |
| 99 | SRC | 0.17664037 |
| 100 | FYN | 0.16345578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 15.6781097 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.58097317 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 1.49444267 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 1.28196336 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99952062 |
| 6 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95675498 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.91622591 |
| 8 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.90042791 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 0.89163389 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86440262 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85416289 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.81522582 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78159048 |
| 14 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73247439 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 0.71437873 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.71203566 |
| 17 | Nicotine addiction_Homo sapiens_hsa05033 | 0.70779763 |
| 18 | ABC transporters_Homo sapiens_hsa02010 | 0.67826747 |
| 19 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67811498 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67115317 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65861173 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61330959 |
| 23 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61087956 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57514833 |
| 25 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57120326 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.54217612 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 0.51389073 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51148411 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50399683 |
| 30 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49391597 |
| 31 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45884217 |
| 32 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45853726 |
| 33 | Purine metabolism_Homo sapiens_hsa00230 | 0.44024294 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43488857 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.42548495 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 0.42049771 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38866037 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37849916 |
| 39 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37193965 |
| 40 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.36985122 |
| 41 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.35741056 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 0.35528893 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35519505 |
| 44 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35209472 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34728471 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33318883 |
| 47 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.32645071 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32577939 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 0.26998535 |
| 50 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25354034 |
| 51 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24869712 |
| 52 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24459791 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22345580 |
| 54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22271806 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21679131 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20792731 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.20060470 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19888630 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.19550752 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.19505903 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.19148600 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.18356427 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.18317834 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.18287681 |
| 65 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18235323 |
| 66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18130550 |
| 67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.17935971 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17864019 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.16489101 |
| 70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.16389065 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.15914886 |
| 72 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13533229 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13492368 |
| 74 | Long-term depression_Homo sapiens_hsa04730 | 0.13237192 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.13224365 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12165637 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.12145161 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.11833961 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.11795702 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.11200642 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.11088728 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.10781609 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.10736268 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.10669943 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.10648861 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.10638166 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.10334132 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.10306399 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.10296869 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.09347433 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.09263714 |
| 92 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.08887860 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.08414524 |
| 94 | Melanogenesis_Homo sapiens_hsa04916 | 0.07965247 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.07714351 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.06007548 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.05305494 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.04791764 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.04784011 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.04181576 |

